(CIGB) The human Recombinant Interferon alfa-2B, developed in 1986 by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB in its Spanish acronym), has benefitted thousands of Cuban patients since its inception in the Cuban health system more than three decades ago, and is one of the medicines being currently used to combat the novel coronavirus COVID-19.
To date, Cuba has not made the decision to close our borders to travelers from any country, but careful follow-up has been established for all passengers, especially those arriving from high risk nations.
At Havana's José Martí International Airport, the flow of travelers continues to be normal, and no flights have been cancelled, to date. Surveillance measures, however, are being reinforced, based on the confirmation of Covid-19 cases in Cuba.
Granma journalist and photographer capture the events on site to tell the story of a historic humanitarian effort.
A Granma journalist and photographer capture the events onsite to tell the story of a historic humanitarian effort, as Cuba mobilizes to transport over 600 passengers and crew members on the cruise ship MS Braemar, from the port of Mariel, west of Havana, to José MartÍ International Airport, following all recommendations of the World Health Organization regarding Covid-19.
All 28,268 members of Cuba’s 61 medical brigades working abroad are free of the coronavirus, reports Dr. Jorge Hidalgo Bustillo, director of the Medical Collaboration Central Unit.
For those who love their family members and their compatriots, the spreading Covid-19 pandemic is cause for alarm, given the risk faced by the more than 28,000 Cuban health workers serving on missions around the world.
But it seems that their solidarity and internationalist vocation has been, thus far, a moral repellent.